Tsukuba, Japan

Haruhide Kimura

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Chemical Industries, Inc.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruhide Kimura. Retrieved from https://idiyas.com/inventor/haruhide-kimura-v99qzdyt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haruhide Kimura: Innovator in Heart Disease Research

Introduction

Haruhide Kimura is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of medical research, particularly in the area of heart diseases. His innovative work has led to the development of important therapeutic solutions.

Latest Patents

Haruhide Kimura holds a patent for "Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases." This patent addresses critical aspects of heart health and offers potential treatments for various heart conditions. He has 1 patent to his name, showcasing his dedication to advancing medical science.

Career Highlights

Kimura is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company known for its commitment to research and development. His role at Takeda has allowed him to work on groundbreaking projects that aim to improve patient outcomes in cardiovascular health.

Collaborations

Throughout his career, Haruhide Kimura has collaborated with esteemed colleagues, including Seiichi Tanida and Tatsuhiko Kaneko. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of heart disease.

Conclusion

Haruhide Kimura's contributions to heart disease research exemplify the impact of dedicated inventors in the medical field. His work continues to inspire advancements that may lead to better health outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…